SecBot SecBot
425 ·Filed Oct 20, 2026

PSNL

Personalis, Inc.
NEUTRAL
Impact 5/10
Horizonweeks Processed27d 8h ago SEC0001193125-26-426862
Rule 425 M&A communications
Actionable Insight • Neutral

The HSR clearance removes a key regulatory hurdle, but the deal still requires stockholder approval and SEC effectiveness of the S-4. Watch for the proxy mailing date and any stockholder opposition or litigation. The employee FAQ signals management's confidence in closing by year-end, but the lack of a definitive stockholder meeting date leaves timeline risk.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$15.90
T+0 close · Oct 20, 2026 · via day close
Latest settled
+0.50%
T+5 · $15.98 · next T+20 tomorrow
Vs SPY
+0.95%
α at T+5
Latest observation
+1.20%
T+16 · FF3 residual α
  1. T+0 · Oct 21 $15.90entry
  2. T+1 · 26d ago −0.50%α +0.68% · $15.82
  3. T+5 · 20d ago +0.50%α +0.95% · $15.98
  4. T+18 · todayOpen
  5. T+20 · tomorrow Pending
  6. T+60 · in 2mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Personalis filed an Employee FAQ (Rule 425) on October 20, 2026, providing deal updates for the pending acquisition by Tempus AI. The transaction is expected to close in late 2026, with the HSR waiting period having expired on October 2, 2026. The filing emphasizes no anticipated layoffs, continued operation of the Fremont site, and the critical importance of the NeXT Personal MRD test to the combined company's future revenue growth, referencing a $20 billion MRD market opportunity.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Transaction expected to close in late 2026, subject to remaining closing conditions.
  • HSR waiting period expired on October 2, 2026, per the cross-filed 8-K.
  • No layoffs anticipated; Tempus acquiring for differentiated products and talent, not cost savings.
  • NeXT Personal MRD test described as critical to combined company's future revenue growth; MRD market estimated at $20 billion.
  • Personalis Fremont headquarters and lab will continue to operate.
  • Employee equity awards (options, RSUs) will convert to Tempus Class A common stock or cash at Tempus election.
  • ESPP will end on or before closing; no new enrollments or increased deductions since merger agreement signed.
  • Stockholder meeting date not yet announced; proxy statement/prospectus not yet effective.

Financial Impact

No financial figures disclosed in this filing. Deal value and exchange ratio not stated.

Risk Factors

  • Stockholders may not approve the merger agreement.
  • Closing could be delayed or not occur if other conditions are not satisfied or waived.
  • Integration risks and potential employee retention challenges post-close.
  • Out-of-the-money options will be cancelled without consideration, potentially affecting morale.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001193125-26-426862
Document: 0001193125-26-426862-index-headers.html0001193125-26-426862
Document: 0001193125-26-426862-index.html0001193125-26-426862
Document: 0001193125-26-426862.txt0001193125-26-426862

Track record

29 reports on PSNL

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +18.82% at T+60 after the Jul 20, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.16 Now $14.80 −2.34% settles Feb 12
  2. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $15.71 Now $14.80 −5.79% settles Feb 11
  3. Nov 12, 20264d ago 425 Neutral 4/10 Entry $15.86 Now $14.80 −6.68% settles Feb 10
  4. Nov 6, 202610d ago 425 Neutral 3/10 Entry $15.95 Now $14.80 −7.21% settles Feb 5
  5. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $15.55 Now $14.80 −4.82% settles Feb 3
  6. Nov 3, 202613d ago 425 Neutral 3/10 Entry $15.79 Now $14.80 −6.27% settles Feb 2
  7. Oct 30, 202617d ago 425 Neutral 4/10 Entry $15.76 Now $14.80 −6.09% settles Jan 29
  8. Oct 21, 202626d ago DEFM14A Neutral 5/10 Entry $15.82 Now $14.80 −6.45% settles Jan 20
  9. Oct 20, 202627d ago 425 Neutral 4/10 Entry $15.90 Now $14.80 −6.92% settles Jan 19
  10. Oct 20, 202627d ago 425 Neutral 5/10 Viewing Entry $15.90 Now $14.80 −6.92% settles Jan 19
Showing 10 of 29

US Market Status

Market Closed · Opens in 8h 47m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 20, 2026